305 related articles for article (PubMed ID: 34802211)
1. [Clinical Trial Progress and Application of Immune Checkpoint Inhibitors
in the Treatment of Small Cell Lung Cancer].
Zhang H; Li X; Li X; Su Y
Zhongguo Fei Ai Za Zhi; 2021 Nov; 24(11):790-795. PubMed ID: 34802211
[TBL] [Abstract][Full Text] [Related]
2. [Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of
Small Cell Lung Cancer].
Huang B; Duan Y
Zhongguo Fei Ai Za Zhi; 2019 Apr; 22(4):239-244. PubMed ID: 31014443
[TBL] [Abstract][Full Text] [Related]
3. [Progress of PD-1/PD-L1 inhibitors in the treatment of small-cell lung cancer].
Zhang SY; Wang Y
Zhonghua Zhong Liu Za Zhi; 2021 Jan; 43(1):98-103. PubMed ID: 33472320
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy versus standard chemotherapy for treatment of extensive-stage small-cell lung cancer: a systematic review.
Liu X; Xing H; Zhang H; Liu H; Chen J
Immunotherapy; 2021 Aug; 13(12):989-1000. PubMed ID: 34114477
[TBL] [Abstract][Full Text] [Related]
5. Rationale for chemotherapy, immunotherapy, and checkpoint blockade in SCLC: beyond traditional treatment approaches.
Spigel DR; Socinski MA
J Thorac Oncol; 2013 May; 8(5):587-98. PubMed ID: 23546044
[TBL] [Abstract][Full Text] [Related]
6. Progress in the clinical application of immune checkpoint inhibitors in small cell lung cancer.
He J; Hu Q
Front Immunol; 2023; 14():1126582. PubMed ID: 37063927
[TBL] [Abstract][Full Text] [Related]
7. [New Advances in the Treatment for Small Cell Lung Cancer].
Cui X; Song P; Zhang L
Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):355-362. PubMed ID: 31196369
[TBL] [Abstract][Full Text] [Related]
8. Advances in immune checkpoint inhibitors therapy for small cell lung cancer.
Li L; Liang Y; Yu M; Zhao L; Mei Q; Yu Y; Wang N; Zhang D; Wang Z; Jia Y; Kong F
Cancer Med; 2023 May; 12(10):11097-11106. PubMed ID: 36880420
[TBL] [Abstract][Full Text] [Related]
9. The landscape of immune checkpoint inhibitor therapy in advanced lung cancer.
Wang C; Li J; Zhang Q; Wu J; Xiao Y; Song L; Gong H; Li Y
BMC Cancer; 2021 Aug; 21(1):968. PubMed ID: 34454455
[TBL] [Abstract][Full Text] [Related]
10. Emerging drugs for small cell lung cancer: a focused review on immune checkpoint inhibitors.
Reddy HG; Qin A; Kalemkerian GP
Expert Opin Emerg Drugs; 2020 Sep; 25(3):353-366. PubMed ID: 32683991
[TBL] [Abstract][Full Text] [Related]
11. The efficiency and safety of immune checkpoint inhibitors in the treatment of small cell lung cancer: a meta-analysis.
Zhang S; Bi M
Ann Palliat Med; 2020 Nov; 9(6):4081-4088. PubMed ID: 33302668
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
Medikonda R; Pant A; Lim M
Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
[TBL] [Abstract][Full Text] [Related]
13. Use of Immunotherapy in Extensive-Stage Small Cell Lung Cancer.
Konala VM; Madhira BR; Ashraf S; Graziano S
Oncology; 2020; 98(11):749-754. PubMed ID: 32663833
[TBL] [Abstract][Full Text] [Related]
14. Immune checkpoint inhibitors in lung cancer: current status and future directions.
Fan Y; Mao W
Chin Clin Oncol; 2017 Apr; 6(2):17. PubMed ID: 28482670
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for small-cell lung cancer: emerging evidence.
Reck M; Heigener D; Reinmuth N
Future Oncol; 2016 Apr; 12(7):931-43. PubMed ID: 26882955
[TBL] [Abstract][Full Text] [Related]
16. Tackling the current dilemma of immunotherapy in extensive-stage small cell lung cancer: A promising strategy of combining with radiotherapy.
Kang K; Wu Y; Yao Z; Lu Y
Cancer Lett; 2023 Jul; 565():216239. PubMed ID: 37211066
[TBL] [Abstract][Full Text] [Related]
17. [Clinical Development of Immune Checkpoint Inhibitors in Patients with Small Cell Lung Cancer].
Zhang S; Liu J; Cheng Y
Zhongguo Fei Ai Za Zhi; 2017 Sep; 20(9):623-628. PubMed ID: 28935016
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer.
Schlick B; Shields MD; Marin-Acevedo JA; Patel I; Pellini B
Curr Treat Options Oncol; 2022 Aug; 23(8):1104-1120. PubMed ID: 35716328
[TBL] [Abstract][Full Text] [Related]
19. The Role of Performance Status in Small-Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors.
Friedlaender A; Liu SV; Passaro A; Metro G; Banna G; Addeo A
Clin Lung Cancer; 2020 Nov; 21(6):e539-e543. PubMed ID: 32499210
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
